Alterity Therapeutics Ltd (ATHE)
2.06
-0.08
(-3.74%)
USD |
NASDAQ |
May 03, 15:39
Alterity Therapeutics Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 5.191M |
| May 01, 2024 | 5.629M |
| April 30, 2024 | 4.862M |
| April 29, 2024 | 5.592M |
| April 26, 2024 | 7.893M |
| April 25, 2024 | 6.067M |
| April 24, 2024 | 6.579M |
| April 23, 2024 | 5.118M |
| April 22, 2024 | 5.118M |
| April 19, 2024 | 4.460M |
| April 18, 2024 | 5.191M |
| April 17, 2024 | 4.241M |
| April 16, 2024 | 4.533M |
| April 15, 2024 | 7.455M |
| April 12, 2024 | 11.03M |
| April 11, 2024 | 8.77M |
| April 10, 2024 | 5.556M |
| April 09, 2024 | 3.511M |
| April 08, 2024 | 3.292M |
| April 05, 2024 | 3.292M |
| April 04, 2024 | 2.963M |
| April 03, 2024 | 2.999M |
| April 02, 2024 | 2.926M |
| April 01, 2024 | 3.803M |
| March 28, 2024 | 4.679M |
| Date | Value |
|---|---|
| March 27, 2024 | 4.314M |
| March 26, 2024 | 2.707M |
| March 25, 2024 | 2.050M |
| March 22, 2024 | 2.488M |
| March 21, 2024 | 2.488M |
| March 20, 2024 | 2.050M |
| March 19, 2024 | 1.758M |
| March 18, 2024 | 2.707M |
| March 15, 2024 | 2.415M |
| March 14, 2024 | 2.707M |
| March 13, 2024 | 3.218M |
| March 12, 2024 | 1.684M |
| March 11, 2024 | 2.050M |
| March 08, 2024 | 2.013M |
| March 07, 2024 | 1.684M |
| March 06, 2024 | 2.050M |
| March 05, 2024 | 2.342M |
| March 04, 2024 | 2.196M |
| March 01, 2024 | 2.196M |
| February 29, 2024 | 3.218M |
| February 28, 2024 | 3.474M |
| February 27, 2024 | 3.438M |
| February 26, 2024 | 2.999M |
| February 23, 2024 | 2.050M |
| February 22, 2024 | 4.460M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-12.11M
Minimum
Dec 28 2022
59.91M
Maximum
Jul 08 2021
9.354M
Average
3.657M
Median
Feb 07 2024
Enterprise Value Benchmarks
| Kazia Therapeutics Ltd | 5.265M |
| Immutep Ltd | -- |
| Opthea Ltd | 118.00M |
| Mesoblast Ltd | -- |
| Immuron Ltd | 3.279M |